0.4000
+0.0050
+(1.27%)
At close: 3:57:59 PM GMT+10
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-4,322.9240
-4,322.9240
-7,024.5740
-6,061.1600
-5,260.3770
Investing Cash Flow
-174.3370
-174.3370
-292.2670
-411.9020
2,978.6020
Financing Cash Flow
5,914.4880
5,914.4880
-267.9780
16,873.9600
-49.1860
End Cash Position
9,233.1920
9,233.1920
7,812.5110
15,394.8470
4,998.5640
Interest Paid Supplemental Data
40.7660
40.7660
59.5240
--
--
Capital Expenditure
-174.3370
-174.3370
-292.2670
-411.9020
-785.8320
Issuance of Capital Stock
6,750
6,750
--
18,461.7160
286.4790
Repurchase of Capital Stock
-508.5350
-508.5350
--
-1,240.3460
--
Free Cash Flow
-4,497.2610
-4,497.2610
-7,316.8410
-6,473.0620
-6,046.2090
6/30/2021 - 1/28/1988
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RHY.AX Rhythm Biosciences Limited
0.0790
+1.28%
WFL.AX Wellfully Limited
0.0030
0.00%
GSS.AX Genetic Signatures Limited
0.3850
+2.67%
PEB.AX Pacific Edge Limited
0.1150
0.00%
CTE.AX Cryosite Limited
0.7950
0.00%
GTG.AX Genetic Technologies Limited
0.0390
0.00%
MAP.AX Microba Life Sciences Limited
0.1900
-2.56%
BDX.AX BCAL Diagnostics Limited
0.0890
0.00%
IBX.AX Imagion Biosystems Limited
0.0140
0.00%
ACL.AX Australian Clinical Labs Limited
2.9500
-0.67%